Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
Padula WV, Larson RA, Dusetzina SB, Apperley JF, Hehlmann R, Baccarani M, Eigendorff E, Guilhot J, Guilhot F, Hehlmann R, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Saussele S, Schiffer CA, Silver RT, Simonsson B, Conti RM.
Padula WV, et al.
J Natl Cancer Inst. 2016 Mar 4;108(7):djw003. doi: 10.1093/jnci/djw003. Print 2016 Jul.
J Natl Cancer Inst. 2016.
PMID: 26944912
Free PMC article.